Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 18.62% vs 17.38% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 27.11% vs 61.97% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 90.56% vs 36.60% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 15.75% vs 41.14% in Mar 2024
Compare Profit and Loss Results of QMS Medical
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
144.00
147.00
-3.00
-2.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
144.00
147.00
-3.00
-2.04%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-9.00
9.00
100.00%
Raw Materials Consumed
81.00
111.00
-30.00
-27.03%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
7.00
15.00
-8.00
-53.33%
Operating Expenses
6.00
0.00
6.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
11.00
-7.00
-63.64%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
10.00
4.00
40.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
121.00
149.00
-28.00
-18.79%
Operating Profit (PBDIT) excl Other Income
23.00
-2.00
25.00
1,250.00%
Other Income
0.00
8.00
-8.00
-100.00%
Operating Profit (PBDIT)
23.00
5.00
18.00
360.00%
Interest
5.00
1.00
4.00
400.00%
Profit before Depriciation and Tax
17.00
4.00
13.00
325.00%
Depreciation
3.00
1.00
2.00
200.00%
Profit Before Taxation & Exceptional Items
14.00
2.00
12.00
600.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
2.00
12.00
600.00%
Provision for Tax
4.00
2.00
2.00
100.00%
Profit After Tax
10.00
0.00
10.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
30.00
84.00
-54.00
-64.29%
Profit Available for appropriations
40.00
85.00
-45.00
-52.94%
Appropriations
40.00
85.00
-45.00
-52.94%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.84
0.3
5.54
1,846.67%
Profit And Loss - Net Sales
Net Sales 144.87 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.62% vs 17.38% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 27.11% vs 61.97% in Mar 2024
Profit And Loss - Interest
Interest 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 90.56% vs 36.60% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 10.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 15.75% vs 41.14% in Mar 2024






